Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
Zurich American Insurance Company | Zurich Insurance | financial services | price-fixing or anti-competitive practices | 2006 | $171,700,000 |
AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | $170,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | $169,000,000 |
Student CU Connect CUSO, LLC | | | consumer protection violation | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $168,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000 |
Volkswagen AG | Volkswagen | motor vehicles | environmental violation | 2017 | $157,000,000 |
Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | $154,000,000 |
McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2012 | $151,000,000 |
Brown & Williamson Tobacco | British American Tobacco | tobacco | tobacco litigation | 2003 | $150,000,000 |
JPMorgan Chase | JPMorgan Chase | financial services | investor protection violation | 2015 | $150,000,000 |
Hikma Pharmaceuticals | Hikma Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | $150,000,000 |
Uber Technologies | Uber Technologies | miscellaneous services | privacy violation | 2018 | $148,000,000 |
Pershing Square Capital Management | | | investor protection violation | 2017 | $145,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | investor protection violation | 2017 | $145,000,000 |
Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $142,494,000 |
Intuit, Inc. | Intuit | information technology | consumer protection violation | 2022 | $141,000,000 |
WellCare Health Plans Inc. | Centene | healthcare services | False Claims Act and related | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $137,500,000 |
Ocwen Financial Services | Ocwen Financial | financial services | mortgage abuses | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $127,300,000 |
AIM Advisors | Invesco | financial services | investor protection violation | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $125,000,000 |
Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | $125,000,000 |
Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $125,000,000 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | kickbacks and bribery | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $123,772,464 |
Maxim Healthcare Services, Inc. | Maxim Healthcare Services | miscellaneous services | False Claims Act and related | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $121,514,199 |
General Motors Company | General Motors | motor vehicles | motor vehicle safety violation | 2017 | $120,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | $120,000,000 |
Lender Processing Services, Inc. | | | mortgage abuses | 2013 | $120,000,000 |
Practice Fusion, Inc. | Allscripts Healthcare Solutions | information technology | kickbacks and bribery | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,600,000 |
Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
UHS, Inc and UHS of Delaware, Inc. | Universal Health Services Inc. | healthcare services | False Claims Act and related | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $117,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | $116,860,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Sharp Corporation | Foxconn Technology Group (Hon Hai Precision Industry Company) | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | $115,500,000 |
Hartford Financial Services Group, Inc. | Hartford Financial Services | financial services | price-fixing or anti-competitive practices | 2007 | $115,000,000 |
Strong Capital Management Co. | Wells Fargo | financial services | investor protection violation | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $115,000,000 |
Apple Inc. | Apple Inc. | electrical and electronic equipment | consumer protection violation | 2020 | $113,000,000 |
Student Loan Xpress, Inc. | First Citizens BancShares | financial services | consumer protection violation | 2009 | $112,825,000 |
Chimei Innolux Corp. | Chi Mei Corporation | chemicals | price-fixing or anti-competitive practices | 2011 | $110,273,318 |
Goldman Sachs | Goldman Sachs | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $110,000,000 |
Ally Financial | Ally Financial | financial services | mortgage abuses | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $109,628,425 |
Bayer AG | Bayer | chemicals | False Claims Act and related | 2003 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Chase Bank USA N.A. | JPMorgan Chase | financial services | consumer protection violation | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $106,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2014 | $105,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | $103,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | $102,500,000 |
Barclays Bank PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2016 | $100,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $100,000,000 |
Citibank | Citigroup | financial services | price-fixing or anti-competitive practices | 2018 | $100,000,000 |
Mallinckrodt plc | Mallinckrodt | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
Merrill Lynch & Co. Inc. | Bank of America | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | drug or medical equipment safety violation | 2018 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $99,875,000 |
Robert Bosch | Robert Bosch | automotive parts | environmental violation | 2019 | $98,700,000 |
USA Discounters | | | consumer protection violation | 2016 | $95,900,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
Consumer Advocacy Center Inc., dba Premier Student Loan Center | | | consumer protection violation | 2022 | $95,000,000 |
Western Union Financial Services, Inc. | Western Union | financial services | anti-money-laundering deficiencies | 2010 | $94,000,000 |
Colfax Capital Corporation and Culver Capital, LLC, also collectively known as Rome Finance | | | consumer protection violation | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $92,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $90,800,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2012 | $90,000,000 |
Penguin Group (USA) Inc. | Bertelsmann | media | price-fixing or anti-competitive practices | 2014 | $90,000,000 |
Samsung Semiconductor, Inc. and Samsung Electronics Company, Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2007 | $90,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694 |
Nationstar Mortgage dba Mr. Cooper | Mr. Cooper Group | financial services | consumer protection violation | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $86,300,000 |
American Honda Motor Co. Inc. and Honda of America Mfg. Inc. | Honda | motor vehicles | consumer protection violation | 2020 | $85,140,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
ACE, Ltd | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | $80,000,000 |
Bear Stearns & Co. LLC | JPMorgan Chase | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
Deutsche Bank | Deutsche Bank | financial services | investor protection violation | 2002 | $80,000,000 |
J.P. Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
Lehman Brothers Inc. | | | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
UBS Warburg LLC | UBS | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
St. Paul Travelers | Travelers | financial services | price-fixing or anti-competitive practices | 2006 | $77,000,000 |
Cancer Fund of America Inc. | | | consumer protection violation | 2016 | $75,800,000 |
JPMorgan Chase | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $75,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | $75,000,000 |
Fiat Chrysler | Stellantis | motor vehicles | environmental violation | 2019 | $72,500,000 |
Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | $71,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | $70,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | $70,000,000 |
Walgreens Boots Alliance | Walgreens Boots Alliance | retailing | False Claims Act and related | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $69,200,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $68,500,000 |
UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2018 | $68,000,000 |
Bank of America | Bank of America | financial services | price-fixing or anti-competitive practices | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $67,000,000 |
Micron Technology, Inc. | Micron Technology | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $66,774,984 |
BASF Corporation | BASF | chemicals | price-fixing or anti-competitive practices | 2000 | $62,258,250 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $62,000,000 |
First Alliance Mortgage Company | | | mortgage abuses | 2002 | $60,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000 |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | $60,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $60,000,000 |
Wachovia Securities | Wells Fargo | financial services | investor protection violation | 2008 | $60,000,000 |
C.R. Bard, Inc. | Becton Dickinson | medical equipment and supplies | drug or medical equipment safety violation | 2020 | $60,000,000 |
HSBC | HSBC | financial services | mortgage abuses | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $59,500,000 |
Wachovia Bank N.A. | Wells Fargo | financial services | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $58,750,000 |
Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2008 | $58,000,000 |
House of Prince A/S | | | tobacco litigation | 2006 | $55,400,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $55,000,000 |